Oncogenic microtubule hyperacetylation through BEX4-mediated sirtuin 2 inhibition

  • Jin Kwan Lee
  • , Janet Lee
  • , Heounjeong Go
  • , Chang Geun Lee
  • , Suhyeon Kim
  • , Hyun Soo Kim
  • , Hyeseong Cho
  • , Kyeong Sook Choi
  • , Geun Hyoung Ha
  • , Chang Woo Lee

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Five brain-expressed X-linked (BEX) gene members (BEX1–5) are arranged in tandem on chromosome X, and are highly conserved across diverse species. However, little is known about the function and role of BEX. This study represents a first attempt to demonstrate the molecular details of a novel oncogene BEX4. Among BEX proteins, BEX4 localizes to microtubules and spindle poles, and interacts with α-tubulin (α-TUB) and sirtuin 2 (SIRT2). The overexpression of BEX4 leads to the hyperacetylation of α-TUB by inhibiting SIRT2-mediated deacetylation. Furthermore, we found BEX4 expression conferred resistance to apoptotic cell death but led to acquisition of aneuploidy, and also increased the proliferating potential and growth of tumors. These results suggest that BEX4 overexpression causes an imbalance between TUB acetylation and deacetylation by SIRT2 inhibition and induces oncogenic aneuploidy transformation.

Original languageEnglish
Article numbere2336
JournalCell Death and Disease
Volume7
Issue number8
DOIs
StatePublished - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Oncogenic microtubule hyperacetylation through BEX4-mediated sirtuin 2 inhibition'. Together they form a unique fingerprint.

Cite this